blackstoneharness.com

A picture archiving and communication system (PACS) is an imaging technology providing economical and convenient storage as well as access to images. The global picture archiving and communications systems market is expected to gain an upward trajectory owing to explosive adoption of information technology in the healthcare sector.

According to Market Research Future (MRFR), the global picture archiving and communications systems market is expected to register a CAGR of over 4.43% over the assessment period (2016-2023). The attractive advantages of the picture archiving and communications systems such as elimination of manual documentation, error free archiving, digital transmission of data and the greater efficiency and ease associated with the process is driving a large demand.

Get a FREE Sample (Including COVID19 Impact Analysis, Full TOC, Tables and Figures) of Picture Archiving and Communications Systems Market @

The influx of information technology and the ubiquitous availability and adoption of smart devices, emerging web technology, and others is resulting in timely and efficient access to data. Elimination of physical barriers owing to centralization of data is also contributing towards the market growth.

The development of universal image storage and transfer standard for PACS coupled with flexibility to incorporate other standard formats such as PDF is resulting in faster adoption of PACS. The expanding adoption of imaging technologies such as computed tomography (CT) and magnetic resonance imaging (MRI) in the hospitals are other drivers of the market.

Additional factors that are fostering the market demand include the dramatically rising end-users such as hospitals and the increasing incidence of diseases.

Picture Archiving and Communications Systems Market – Segments

The report is segmented into six dynamics to widen the scope of understanding,

By Type: Oncology PACS, Cardiology PACS, Dental PACS, Orthopaedics PACS, among others.

By Components: Hardware (Access Devices, Peripherals, Servers, Storage Devices, and Networking Devices), Software, Services (Consulting, Implementation Services, Post-Sales and Maintenance Services, and Training Services), among others.

By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Nuclear Imaging, X-Ray, Ultrasound, among others.

By Delivery Mode: Cloud-Based (Saas) Delivery Mode, Web-Hosted (On-Demand) Delivery Mode, And On-Premise Mode, among others.

By End-use: Hospitals And Clinics, Healthcare Centers, Imaging Centers, Diagnostic Centers, Clinical Research Institutions, among others.

By Regions: North America, Europe, Asia Pacific, and the Rest-of-the-World.

Global Picture Archiving and Communications Systems Market – Regional Analysis

North America dominates the global picture archiving and communications systems market owing to rapid adoption of technology, presence of large hospitals and the consolidation of healthcare sectors resulting in increase in purchasing power.

The entry of technology companies in the medical devices sector is also boosting the market growth. Moreover, the established healthcare sectors and high healthcare expenditures is driving a substantial demand for the growth of the market.

Europe accounts for another large share of the picture archiving and communications systems market owing to large healthcare expenditure and the proliferating information technology and pharmaceutical industry in the region. The presence of large players in the region is providing a boost to the market growth.

The Asia Pacific picture archiving and communications systems market is expected to be in a flux and represents a bimodal nature. Japan, Australia and South Korea are leading the Asia Pacific market. However, China and India are expected to drive a momentous growth owing to their economic development.

Picture Archiving and Communications Systems Market – Competitive Landscape

The picture archiving and communications systems market is dominated by handful of large firms resulting in a pricing premium on the products. The industry is intensive in terms of intellectual property and technology which makes market entry a challenge for small players.

Manufacturers rely on collaboration and partnerships with other players to innovate new products and to cut down the development costs and time.Manufacturers of picture archiving and communications systems use a variety of distributions channels and are increasingly engaging the social media to generate inbound leads.

Major Players:

Players leading the global picture archiving and communications systemsmarket include Siemens Healthineers, Advanced Data Systems, Allscripts Healthcare Solutions, Inc., Telediagnostics Services Pvt. Ltd.,Konica Minolta Healthcare Americas Inc., Alta Vista Teleradiology, Avreo, Inc., Radiology Imaging Solutions, Scimage, Inc., Brit Systems, Comarch SA, Cybernet Medical Corporation, Virtual Radiology (vRAD),GE Healthcare, INFINITT Healthcare, McKesson Corporation,Inc., ONRAD, Inc., Pacshealth, LLC, FujiFilm Medical Systems, Perfect Imaging, LLC, RamSoft, Inc., Global Diagnostics, Sectra Imtec AB, Sectra Imtec AB, Singular Medical Technologies, StatRad, LLC, Agfa-Gevaert N.V., Argus Radiology, Telerad Tech Private Limited, among others.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Industry/ Innovation/ Related News:

Sep 11 2018 —-Mercy Technology Services, launched its latest picture archiving communication system (PACS) imaging solution, as a Software as a Service system. The system has an automated workflow orchestrator which auto-coordinates the physicians worklist through speech recognition and reporting technology adopted from Nuance. Mercy has already adopted the system in its care facilities. The system claims to increase report turnaround time by up to 50 percent. The PACS system is an addition to Mercy Technology Servicescloud solution, launched earlier in partnership with VMware.

In this era of genuinely marvelous, high-tech, medical devices, it is sometimes surprising that certain diseases are still diagnosed “clinically,” meaning that the clinician makes the call based on just the story of symptoms and the physical exam. Parkinson’s disease is one such disease. There is no “Parkinson scan” or “Parkinson blood-test” to rely upon. MRI scans, CT scans and blood tests are usually normal in people with this disease.

Of course, once upon a timebefore scans and blood-tests even existedthis is how all diagnoses were made. So, in a sense, diagnosing Parkinson’s disease gets back to the very roots of what doctors are supposed to do. But when there are no corroborative tests available to prove or disprove a diagnosis, even the doctor sometimes gets it wrong.

Before delving into the challenges of diagnosing Parkinson’s disease, let’s first consider what is known about this condition.In 1817 James Parkinson, an English surgeon and apothecary, published a classic, short book entitled “An Essay on the Shaking Palsy.” In it, Parkinson identified a consistent pattern of physical abnormalities in six patients he had examined. Although people with identical abnormalities had doubtlessly been around for thousands of years, Parkinson was the first to recognize this pattern of abnormalities as a distinct condition. For this important achievement, the disease was eventually named for him.

In the book’s opening sentence Parkinson wasted no time in laying out prominent features of this disease: “Involuntary tremulous motion, with lessened muscular power, in parts [of the body] not in action and even when supported; with a propensity to bend the trunk forwards, and to pass from a walking to a running pace: the senses and intellects being uninjured.”

Subsequently, scientists discovered that degeneration of a limited group of brain cells containing the chemical transmitter dopamine was responsible for these clinical changes. (The group of brain cells involved is too slight to show up on brain scans in all but the most advanced of cases.) In 1967, levodopa (one of two ingredients in brand-name Sinemet) a drug the body can convert into dopamine, was found helpful in alleviating many of the symptoms. Later, other drugs (dopamine agonists) were created that improved symptoms by mimicking the action of the missing dopamine. These include bromocriptine (brand name Parlodel), pergolide (Permax), pramipexole (Mirapex) and ropinirole (Requip). To date, there are no treatments that reliably stop or reverse the underlying disease-process.

As a condition that affects about one percent of people over the age of 60, Parkinson’s disease is usually on the radar screen of patients and doctors alike when new symptoms are present that suggest the disease. That other conditions can resemble it was not news to James Parkinson who devoted a chapter of his 1817 book to “Shaking palsy distinguished from other diseases with which it may be confounded.”In my consultation practice of neurology, I see both over-diagnosis and under-diagnosis of Parkinson’s disease. The problem usually centers on one of the most visible of symptoms, the tremor. When tremor of the hands is present, doctors often diagnose Parkinson’s disease, even when another condition is to blame. When tremor is absent, doctors often fail to consider Parkinson’s disease, even when it is present. One key to accurate diagnosis is to focus on the characteristics of the tremor itself. The Parkinsonian tremor usually affects one hand first, and at all stages of the disease the initially affected hand remains more tremulous than the other hand. And, as Parkinson himself emphasized, the tremor is most evident when the hand is at rest or supported, and decreases when the hand is in the air or put to use. In other conditions that cause hand-tremors, the hands are more equally affected, and the tremor is more evident when the hands are in the air or put to use.

What about cases in which no tremor is present? Because symptoms of Parkinson’s disease worsen slowlyyear by year instead of month by monthpatients and their families often mistake these changes as due to normal, healthy aging. Non-tremor symptoms of Parkinson’s disease can include relative immobility of body-parts (hypokinesia), especially of the face which can show a mask-like lack of expression. Movements, once initiated, are slow (bradykinesia). Walking, as James Parkinson noted, involves a bent-forward posture with shuffling, short steps and reduced swinging of the arms. Sometimes the body’s center of gravity gets ahead of the feet’s ability to catch up, resulting in the passing “from a walking to a running pace” that Parkinson described and is known as festination.

The physical exam also shows clumsiness in hands and feet. Increased muscle tone, called “rigidity,” is encountered in the patient’s neck and arm muscles, even while they are supposed to be relaxed.

Patients who have Parkinson’s disease without tremor are often the most gratifying cases to treat. Having developed their problems slowly and having believed all along that their symptoms were due to aging, they are happily astonished by the rapid improvement in function produced by appropriate medication.

(C) 2005 by Gary Cordingley